MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Business/Financial News / Funding Roundup / Spirox lands $19m Series B round

Spirox lands $19m Series B round

April 23, 2015 By Mark Hollmer Leave a Comment

Spirox lands $19m Series B round

Spirox said this week that it nailed down an $18.5 million Series B round to back development and commercialization of its device to treat patients with nasal obstructions.

Venrock and Aisling Capital led the round for Menlo Park, Calif.-based Spirox, with existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participating.

As part of financing, Venrock partner Camille Samuels and Aisling partner Aftab Kherani will join Spirox’s board of directors, along with Stacy Enxing Seng, former president of vascular therapies at Covidien.

Spirox said it is developing a new kind of minimally invasive device to treat patients with nasal obstructions for the ear, nose and throat market. The proceeds are slated for winding up development work and pursuing U.S. marketing authorization and commercial launch, the company said.

Spirox hopes to compete with existing invasive surgical procedures, which carry higher levels of risk. More than 1 million surgeries are performed each year to alleviate nasal obstructions, according to the company.

“We are thrilled to receive support from such a strong syndicate of investors to help us accelerate Spirox towards commercialization,” CEO Duke Rohlen said in prepared remarks. “This funding is further validation of our technology, which has the potential to provide relief for millions of patients suffering from nasal obstruction.”

Filed Under: Funding Roundup, News Well Tagged With: Aisling Capital, Aperture Venture Partners, Correlation Ventures, Ear Nose & Throat (ENT), Otolaryngology/Ear, Spirox, Venrock, Venture Capital/Private Equity, Western Technology Investment

In case you missed it

  • Barry out as InspireMD CEO
  • Report: EtO blood levels higher in Illinois neighbors of Medline sterilization plant
  • FDA clears augmented glenoids for Shoulder Innovations system
  • McKesson names new chief information and technology officer
  • Imperative Care raises $85m
  • CMR Surgical appoints new CEO
  • Peregrine Ventures raises $115m
  • Roche wins CE Mark for blood glucose reading smartphone app
  • Cantel Medical beats The Street in Q1 results
  • FDA details framework for abbreviated 510(k) medical device review pathway
  • Drug or device? FDA loses this argument for now
  • Aptar wins FDA clearance for ready-to-use seizure treatment device
  • Aurora Bio touts PET radiotracer data
  • Medical device excise tax would reduce R&D spending, report says
  • Proteus Digital Health restructuring amid reported funding woes
  • GE Healthcare partnering on regenerative tissue manufacturing
  • Schiller issues field safety notice for Tempus LS defibrillators

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS